期刊文献+

脂联素通过抑制RIP1/RIP3表达对糖尿病肾病小鼠肾脏的保护作用 被引量:4

Protective effect of adiponectin on the kidney in diabetic nephropathy mice by inhibiting the expression of RIP1/RIP3
下载PDF
导出
摘要 目的探讨脂联素对糖尿病肾病小鼠肾脏的保护作用。方法选择30只雄性健康C57BL/6小鼠作为研究对象,其中10只小鼠作为对照组,20只小鼠采用链脲佐菌素(STZ)构建糖尿病肾病(DN)模型。Apn组DN小鼠单次腹腔注射2 mg/kg Apn,每天注射1次,持续6周。STZ处理后10周检测各组小鼠体质量(BW)、左肾质量(KW)、左肾质量/体质量(KW/BW)、平均肾小球体积(MGV),检测肌酐清除率(Ccr)、24 h尿蛋白。采用酶联免疫吸附试验(ELISA)法检测小鼠肾脏组织TNF-α、IL-6的水平。采用苏木精-伊红(HE)染色观察和评定小鼠肾脏组织的病理变化。采用Western blot法检测小鼠肾脏组织中RIP1、RIP3蛋白的表达水平。结果18只小鼠成功构建DN模型,死亡2只。模型组和Apn组小鼠的BW低于对照组,KW、KW/BW以及MGV均高于对照组,且Apn组小鼠的BW比模型组高,KW、KW/BW以及MGV比模型组低,差异均有统计学意义(P<0.01)。模型组和Apn组小鼠的肾脏组织中的TNF-α、IL-6水平以及RIP1、RIP3蛋白的表达水平均明显高于对照组,且Apn组小鼠肾组织中TNF-α、IL-6水平以及RIP1、RIP3蛋白的表达水平均明显低于模型组,差异均有统计学意义(P<0.05)。结论脂联素可能通过RIP1/RIP3通路抑制细胞凋亡坏死,从而减轻糖尿病肾病肾组织的炎症反应和损伤,延缓肾组织的增生,保护肾脏组织。 Objective To explore the protective effect of adiponectin on the kidney of diabetic nephropathy mice.Methods Thirty male healthy C57BL/6 mice were selected as the research objects.Ten mice were chosen as control group,and the other 20 mice were treated with streptozotocin(STZ)to construct the diabetic nephropathy(DN)model.DN mice in Apn group were intraperitoneally injected with 2 mg/kg Apn once a day for 6 weeks.Ten weeks after STZ treatment,body weight(BW),left kidney weight(KW),left kidney weight/body weight(KW/BW),mean glomerular volume(MGV)and creatinine clearance rate(Ccr),24 h urine protein were compared.Enzyme-linked immunosorbent assay(ELISA)was used to detect the levels of TNF-αand IL-6 in mouse kidney tissue.Hematoxylin-Eosin(HE)staining was used to observe the pathological changes of kidney tissue.Western blot was used to detect the expression levels of RIP1 and RIP3 proteins in kidney tissue.Results A total of 18 mice were successful to establish DN models,and two mice died.BW in model group and Apn group were significantly lower than that in control group(P<0.01),while KW,KW/BW and MGV were significantly higher(P<0.01).BW in Apn group was higher than that in model group,while KW,KW/BW and MGV were statistically lower(all P<0.05).The levels of TNF-α,IL-6 and RIP1 and RIP3 proteins in the kidney tissues in model group and Apn group were significantly higher than those in control group(P<0.05),and the levels of TNF-α,IL-6 and RIP1 and RIP3 proteins in the kidney tissue in Apn group were significantly lower than those in model group(P<0.05).Conclusion Adiponectin may inhi-bit the cell apoptosis and the necrosis through the RIP1/RIP3 pathway,thereby reducing the inflammatory response and the damage of kidney tissue in diabetic nephropathy,delaying the proliferation of the kidney tissue,and protecting the kidney tissue.
作者 陈绵雄 林慧 张菊云 刘婷婷 CHEN Mianxiong;LIN Hui;ZHANG Juyun;LIU Tingting(Department of Endocrinology,Haikou Hospital Affiliated to Xiangya,Central South University,Haikou People’s Hospital,Haikou 570208,China)
出处 《山西医科大学学报》 CAS 2020年第9期938-943,共6页 Journal of Shanxi Medical University
基金 海南省医药卫生科研基金项目(15A200002)。
关键词 糖尿病肾病 脂联素 RIP1 RIP3 diabetic nephropathy adiponectin RIP1 RIP3
  • 相关文献

参考文献5

二级参考文献40

  • 1Brosius FC, Khoury CC, Buller CL, et al. Abnormalities in signaling pathways in diabetic nephropathy. Expert Rev Endocrinol Metab, 2010, 5: 51-64.
  • 2Cui J, Panse S, Falkner B. The role of adiponectin in metabolic and vascular disease: a review. Clin Nephrol, 2011, 75: 26-33.
  • 3Ohashi K, Iwatani I-I, Kihara albuminuria and renal fibrosis model of adiponectin-knockout Vasc Biol, 2007, 27:1910-1917 S, et 81. Exacerbation of in subtotal renal ablation mice. Arterioscler Thromb.
  • 4Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 2003, 423: 762-769.
  • 5Cammisotto PG, Bendayan M. Adiponectin stimulatesphosphorylation of AMP-activated protein kinase alpha in renal glomeruli. J Mol Histol, 2008, 39: 579-584.
  • 6Shimotomai T, Kakei M, Narita T, et al. Enhanced urinary adiponectin excretion in IgA-nephropathy patients with proteinuria. Ren Fail, 2005, 27: 323-328.
  • 7Antoniades C, Antonopoulos AS, Tousoulis D, et al. Adiponectin: from obesity to cardiovascular disease. Obes Rev, 2009, 10: 269-279.
  • 8Matsuzawa Y, Funahashi T, Kihara S, et al. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol, 2004, 24: 29-33.
  • 9Funahashi T, Matsuzawa Y. Hypoadiponectinemia: a common basis for diseases associated with ovemutrition. Curr Atheroscler Rep, 2006, 8: 433-438.
  • 10Nakamaki S, Satoh H, Kudoh A, et al. Adiponectin reduces proteinuria in streptozotocin-induced diabetic Wistar rats. Exp Biol Med (Maywood), 2011, 236: 614-620.

共引文献55

同被引文献33

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部